CDSCO issues PUBLIC NOTICE asking for feedback on online portal SUGAM
All stakeholders of SUGAM are requested to provide their valuable feedback as per enclosed format with suggestions about the short-term, medium-term and long-term measures to be taken to improve the system. The feedback should be forwarded to feedback@cdsco.nic.in within 2 weeks of this notice in scanned pdf format as well as excel document format.
New Delhi: The Central Drugs Standard Control Organisation(CDSCO) has sought feedback from users, including manufacturers, importers, research and development institutions, and clinical research organisations about its web portal 'SUGAM' to further improve it.
Through a public notice, CDSCO announced to keep in line with Govt of India's vision to promote Digital India and Ease of Doing Business, CDSCO thrives to strengthen this online SUGAM portal to enhance public confidence in the quality, safety and efficacy of drugs marketed in India as well as to satisfy the applicants.
CDSCO further adds, as "SUGAM" online system (www.cdscoonline.gov.in) has completed 2 years and all stakeholders well converse, it would be appropriate to obtain feedback from the stakeholder to improve the system. A detailed feedback form is enclosed as Annex-I.
All stakeholders are requested to provide their valuable feedback as per the format with suggestions about the short-term, medium-term and long-term measures to be taken to improve the system. The feedback should be forwarded to feedback@cdsco.nic.in within 2 weeks of this notice in scanned pdf format as well as excel document format.
SUGAM is an e-Governance system to discharge various functions performed by the CDSCO under the Drugs and Cosmetics Act, 1940. Through the web portal, people can apply for NOCs, licenses, registration certificates, permissions and approvals. It provides an online interface for applicants to track their applications, respond to queries and download the permissions issued by CDSCO.
It also enables CDSCO officials to process the applications online.
Also Read: Application for Bulk Vaccine to be filed mandatorily through SUGAM: CDSCO
Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd